Properly reconstituted BPC-157 should be a clear, colorless liquid indistinguishable from water. When it isn't — haze, wisps, flakes, yellowing — something has changed. This post covers the five causes, how to tell them apart, and when the vial is still safe.
Before assigning a cause, describe what you see precisely. Four patterns, each with different implications:
| Appearance | Probable cause | Usable? |
|---|---|---|
| Wisps / strings on swirling | Aggregation from shaking or freeze-thaw | Reject |
| Fine haze — looks like slightly milky water | Mild precipitation or early bacterial growth | Reject |
| Visible particles / flakes | Major precipitation, mold, or inorganic contamination | Reject |
| Yellowing (pale straw) | Oxidation or chemical degradation | Reject |
| Transient cloudiness that clears on gentle warming to room temp | Temperature-induced reversible precipitate | Judgement call |
Cold storage can cause solutes (salts, peptide itself) to partially precipitate out of solution. This often shows up as haze on a freshly refrigerated vial that clears as the vial warms to room temperature. It's generally benign — the peptide hasn't degraded, it's just temporarily less soluble. If the cloudiness fully resolves on warming and the liquid returns to visibly clear, the vial is usually still good. If warming doesn't restore clarity, escalate.
BPC-157 in aqueous buffer is physically stable, but peptide chains aggregate under shear stress (vortex, vigorous shaking) or freeze-thaw cycles. Aggregated peptide appears as wisps, strings, or persistent haze. This is irreversible. The aggregated peptide is no longer biologically equivalent, and potency — the thing you're paying for — has measurably dropped.
Bacteriostatic water inhibits, but does not eliminate, microbial growth. At warm temperatures, after weeks of use, or if the stopper has been pierced repeatedly without alcohol wiping, contamination is a real risk. Visible cloudiness from microbial growth often develops over days and is accompanied by a subtle change in smell or, later, visible turbidity. Injecting contaminated peptide is a direct route to abscess, sepsis, or systemic infection.
BPC-157 dissolves cleanly in bacteriostatic water and sterile saline. Some researchers have tried tap water, non-sterile distilled water, or DMSO carriers — each of which can cause immediate or progressive cloudiness. If reconstitution wasn't with BAC water or sterile saline, the vial should be discarded regardless of appearance. See the reconstitution guide for diluent selection.
Occasionally, peptide synthesis leaves trace residual solvent (TFA, acetonitrile) that can interact unpredictably with the benzyl alcohol in BAC water or with the stopper material on prolonged storage. This is a supplier-quality issue — consistent cloudiness across multiple vials from the same batch is a signal to check the Certificate of Analysis and consider a different supplier.
Not reliably. Visible cloudiness on injectables is a conservative reject — discard and reconstitute a new vial. Visual inspection cannot distinguish reversible precipitation from aggregation or contamination.
Temperature-induced precipitation can be reversible. A cold vial may show transient haze that clears on gentle warming. Transient, resolving cloudiness is a different phenomenon from aggregation or contamination, but any persistent or recurring haze should be rejected.
BAC water suppresses microbial growth for up to ~28 days of intermittent use. It does not prevent chemical degradation, aggregation, or temperature precipitation.
Yes. Shear stress from shaking or vortexing promotes aggregation, which presents as wisps or persistent haze. Swirl or invert gently.
Filter-sterilization (0.22 µm) removes particulate and microbial load but does not restore lost potency and cannot remove dissolved chemical degradants. At home, discarding is the safer path.
Peptide Protocol timestamps reconstitution and warns you before a vial crosses its shelf-life window. Fewer vials go cloudy on your watch.
Get the iPhone app →Informational and educational only. Not medical advice. Consult a licensed clinician before starting, changing, or stopping any peptide protocol. Any mention of BPC-157 is in a research / investigational context; BPC-157 is not FDA-approved.